✓ Plata cu cardul restabilită — finalizare securizată prin Privacy Shield

Dinex Ec

Dinex EC (Didanosine 250/400 mg) — Cipla older NRTI for HIV. Reserved for salvage therapy. FDA black-box pancreatitis, lactic acidosis, and peripheral neuropathy warnings.

Verificat medical de Morgan Ellis — Cercetător farmaceutic · 8 ani de experiență  · Ultima recenzie: mai 2026

Plată criptată
Plățile în crypto reduc prețul cu 10%
Livrare discretă în întreaga lume
1.400+ clienți · 50+ țări

Acest produs este momentan indisponibil și nu poate fi comandat.

Răspuns rapid

Dinex EC — didanosine 250/400 mg enteric-coated capsule (Cipla). NRTI for HIV — older agent, now reserved for salvage therapy or settings where modern NRTIs are unavailable. Mitochondrial toxicity (peripheral neuropathy, pancreatitis, lactic acidosis) limits use.

Ce beneficii oferă MedsBase:

  • producător certificat WHO-GMP
  • Ambalaj discret în plic simplu
  • Livrare în toată lumea
  • Evaluat de peste 1.400 de clienți (citește recenziile)

📦 Garanția de retransmitere: dacă comanda dvs. nu a ajuns în 20 de zile lucrătoare de la expediere, o retransmitem fără costuri suplimentare. Citește politica.

De ce să comanzi de la MedsBase

Dinex EC ships from a WHO-GMP certified manufacturer in plain packaging, billed through a regulated payment processor (the statement descriptor reads a regulated card-payment processor — never MedsBase or any medication name). Every order carries our 20-business-day Reshipment Assurance.

FDA black-box: pancreatitis + lactic acidosis
Didanosine carries multiple black-box warnings: fatal lactic acidosis with hepatic steatosis (especially with stavudine or in pregnancy), severe pancreatitis (5-7% incidence — fatal cases reported), peripheral neuropathy (12-34%), retinal changes/optic neuritis. Modern HIV care has largely retired didanosine.

Întrebări frecvente

Why is didanosine still used?

Resource-limited settings, salvage regimens after multiple-drug-resistant HIV, or specific historical situations. Modern guidelines use TDF or TAF (or abacavir) + lamivudine/emtricitabine instead — much better safety profile.

Pancreatitis warning?

5-7% develop pancreatitis. Stop immediately if abdominal pain + raised amylase/lipase. Avoid combining with other pancreatitis-risk drugs (alcohol, valproate, hypertriglyceridaemia).

Peripheral neuropathy?

Common (12-34%) and dose-related. Usually reversible if drug stopped early. Stavudine combination compounds risk — never combine d4T + ddI.

Lactic acidosis?

Mitochondrial toxicity feature. More common with d4T+ddI combination, in women, in pregnancy, in obesity. Symptoms: malaise, fatigue, abdominal pain, breathlessness, nausea. Stop drug immediately.

Interacțiuni medicamentoase?

Tenofovir + didanosine raises ddI levels — avoid combination or reduce ddI dose. Allopurinol raises ddI levels (avoid). Methadone reduces ddI levels (clinically minor).

Sarcină?

Avoid in pregnancy due to lactic acidosis risk (especially with d4T).

Ce fac dacă uit o doză?

Take when you remember if same day; otherwise skip. Do not double up. Adherence is critical — and this drug is hard to take consistently due to food restrictions and side effects.

Empty stomach?

Older formulations needed empty stomach; the EC formulation is taken on an empty stomach (1 hour before or 2 hours after a meal) — food reduces absorption ~50%.

When should it be stopped?

Severe pancreatitis (any), peripheral neuropathy progression, lactic acidosis, retinal changes, or virological failure all mandate stopping or substituting. Most patients on ddI in modern care should be discussed with HIV specialist for switch to safer alternatives.

Long-term outlook?

Almost all HIV patients in modern care should be on a TDF or TAF or abacavir-based regimen with INSTI third agent. Continued ddI use should be reviewed at every clinic visit with a clear plan to switch when safer alternatives become available.

Other HIV & Antiviral Medications

  • Trioday — TDF + 3TC + EFV — single-tablet regimen by Cipla
  • Triomune — d4T + 3TC + NVP — older 3-in-1 (stavudine-based)
  • Zepdon — raltegravir 400 mg — integrase inhibitor
  • Abamune L — abacavir + lamivudine — alternative NRTI backbone
  • Tenvir L — tenofovir + lamivudine — alternative NRTI backbone
Disclaimer medical: HIV treatment is a complex, lifelong therapy. Drug choice depends on genotype, resistance testing, comorbidities, and prior treatment history. Discuss any regimen change with an HIV specialist. Adherence >95% is required to prevent resistance. Test for HBV before starting any tenofovir-, lamivudine-, or emtricitabine-containing regimen — withdrawal can cause severe HBV flare in co-infected patients.

More options in HIV Medication

Clasificate în funcție de volumul recent de comenzi MedsBase — ce aleg alți clienți în această categorie.

Concentrație

250 mg, 400 mg

Cantitate

30 Comprimate/s, 60 Comprimate/s, 90 Comprimate/s

Formă farmaceutică

Comprimat/e

Producător

Cipla Inc

Indicație

HIV Infection

Brand generic

Didanosine

Recenzii

Nu există recenzii încă

Adăugați o recenzie
Dinex Ec Dinex Ec
Evaluare*
0/5
* Evaluarea este obligatorie
* Răspunsul este obligatoriu
Recenzia dvs.
* Recenzia este obligatorie
Nume
* Numele este obligatoriu
Adăugați fotografii sau videoclip la recenzia dvs.

Întrebări și răspunsuri

Pune o întrebare
Dinex Ec Dinex Ec
Întrebarea ta
* Întrebarea este obligatorie
Nume
* Numele este obligatoriu
Nu există întrebări încă